Chemoinformaics analysis of (Z)-ICOS-9-ENOIC ACID
| Molecular Weight | 310.522 | nRot | 17 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 0 |
| Exact Molecular Weight | 310.287 | nRing | 0 |
| Solubility: LogS | -6.799 | nHRing | 0 |
| Solubility: LogP | 7.095 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 60.3421 |
| nHD | 1 | BPOL | 38.9899 |
| QED | 0.462 |
| Synth | 2.854 |
| Natural Product Likeliness | 0.825 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.025 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.424 |
| MDCK | 0.00000924 |
| BBB | 0.453 |
| PPB | 0.977563 |
| VDSS | 2.667 |
| FU | 0.0214323 |
| CYP1A2-inh | 0.583 |
| CYP1A2-sub | 0.215 |
| CYP2c19-inh | 0.447 |
| CYP2c19-sub | 0.754 |
| CYP2c9-inh | 0.539 |
| CYP2c9-sub | 0.907 |
| CYP2d6-inh | 0.087 |
| CYP2d6-sub | 0.039 |
| CYP3a4-inh | 0.148 |
| CYP3a4-sub | 0.148 |
| CL | 7.198 |
| T12 | 0.067 |
| hERG | 0.028 |
| Ames | 0.005 |
| ROA | 0.024 |
| SkinSen | 0.882 |
| Carcinogencity | 0.045 |
| EI | 0.968 |
| Respiratory | 0.242 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.564986 |